Northwest Capital Management’s Zimmer Biomet ZBH Stock Holding History

Northwest Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-25	Closed	-$2.83K	–	449
2025 Q1	$2.83K	Hold	25	–	–	﹤0.01%	382
2024 Q4	$2.64K	Hold	25	–	–	﹤0.01%	379
2024 Q3	$2.7K	Hold	25	–	–	﹤0.01%	396
2024 Q2	$2.71K	Hold	25	–	–	﹤0.01%	391
2024 Q1	$3.3K	Sell	25 -40	-62%	-$5K	﹤0.01%	462
2023 Q4	$7.91K	Buy	65 +25	+63%	+$2.79K	﹤0.01%	398
2023 Q3	$4.49K	Hold	40	–	–	﹤0.01%	431
2023 Q2	$5.82K	Buy	+40	New	+$5.44K	﹤0.01%	423

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northwest Capital Management's ZBH Position: Q2 2025 in Review

Northwest Capital Management sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 25 shares — an estimated $2.83K sold.

Northwest Capital Management first reported a position in ZBH in Q2 2023 and held it in 8 quarters. The position peaked at $7.91K in Q4 2023. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

Northwest Capital Management reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
Northwest Capital Management sold 25 Zimmer Biomet shares in Q2 2025, an estimated $2.83K.
Northwest Capital Management first reported a position in Zimmer Biomet in Q2 2023 and held it in 8 quarters.
Northwest Capital Management's Zimmer Biomet position peaked at $7.91K in Q4 2023.
934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on Northwest Capital Management's 13F filing for Q2 2025, filed 25 Jul 2025.